DHTI (Dalrada Technology Group) Debt-to-EBITDA : -1.58 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Dalrada Technology Group Debt-to-EBITDA?

Dalrada Technology Group DHTI -1.50% Debt-to-EBITDA is -1.58 as of Mar. 2026. The stock has 8 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Dalrada Technology Group ranks worse than 209643.4% on this metric.

Debt-to-EBITDA measures a company's ability to pay off its debt.

Dalrada Technology Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was $10.65 Mil. Dalrada Technology Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was $8.43 Mil. Dalrada Technology Group's annualized EBITDA for the quarter that ended in Mar. 2026 was $-12.11 Mil. Dalrada Technology Group's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 was -1.58.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Dalrada Technology Group's Debt-to-EBITDA or its related term are showing as below:

DHTI' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -4.42   Med: -0.71   Max: 17.19
Current: -1.1

During the past 13 years, the highest Debt-to-EBITDA Ratio of Dalrada Technology Group was 17.19. The lowest was -4.42. And the median was -0.71.

DHTI's Debt-to-EBITDA is ranked worse than
100% of 477 companies
in the Healthcare Providers & Services industry
Industry Median: 2.22 vs DHTI: -1.10

Dalrada Technology Group  (OTCPK:DHTI) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Dalrada Technology Group Debt-to-EBITDA Related Terms


Dalrada Technology Group Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Dalrada Technology Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dalrada Technology Group Debt-to-EBITDA Chart

Dalrada Technology Group Annual Data
Trend Jun05 Jun06 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.19 -2.47 -0.49 -0.41 -0.71

Dalrada Technology Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.12 -0.62 -0.78 -1.29 -1.58

DHTI vs PMHS, RDGT, BLMH: Debt-to-EBITDA Comparison

For the Pharmaceutical Retailers subindustry, Dalrada Technology Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dalrada Technology Group Debt-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dalrada Technology Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Dalrada Technology Group's Debt-to-EBITDA falls into.



Dalrada Technology Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Dalrada Technology Group's Debt-to-EBITDA for the fiscal year that ended in Jun. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(5.416 + 9.093) / -20.462
=-0.71

Dalrada Technology Group's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(10.652 + 8.425) / -12.108
=-1.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →
What does a Debt-to-EBITDA of -1.58 mean?
Dalrada Technology Group (DHTI) has a Debt-to-EBITDA of -1.58 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Dalrada Technology Group. According to the industry distribution chart, Dalrada Technology Group ranks #999999 out of 477 companies in the Healthcare Providers & Services industry.
Is Dalrada Technology Group's Debt-to-EBITDA too high?
Dalrada Technology Group's current Debt-to-EBITDA is -1.58. Based on the distribution chart, Dalrada Technology Group ranks #999999 out of 477 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Dalrada Technology Group's Debt-to-EBITDA compare to PMHS and RDGT?
According to the Healthcare Providers & Services industry distribution chart, Dalrada Technology Group ranks #999999 out of 477 companies for Debt-to-EBITDA. This places Dalrada Technology Group in the lower half of its industry. The industry median Debt-to-EBITDA is 2.22. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.22, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Dalrada Technology Group. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dalrada Technology Group's current Debt-to-EBITDA is -1.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dalrada Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Dalrada Technology Group (DHTI) is currently considered Possible Value Trap. The stock's GF Value™ is $0.05, compared to a current price of $0.02 — trading 60.6% below its estimated fair value. The current Debt-to-EBITDA is -1.58. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Dalrada Technology Group (DHTI), the current Debt-to-EBITDA is -1.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dalrada Technology Group Business Description

Address 600 La Terraza Boulevard, Escondido, CA, USA, 92025
Dalrada Technology Group Inc is a United States-based company engaged in providing commercial and home heat pumps, building advanced physical deposition solutions for semiconductor manufacturers and clean energy applications, and driving enhanced healthcare initiatives through its subsidiaries like specialty pharmacy. Its business segments include: Climate Technology; Deposition Technology; and Genefic Healthcare.